C.R. Bard, Inc. (NYSE:BCR)

CAPS Rating: 5 out of 5

The Company is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.

Recs

0
Player Avatar DrGoldin (98.46) Submitted: 1/14/2013 12:24:36 AM : Outperform Start Price: $101.32 BCR Score: -1.05

No pitch for C.R. Bard since 2011? They're profitable. They're CONSISTENTLY profitable. They're in a sector that can only improve. The price is reasonable. What's not to like?

Report this Post Reply

Featured Broker Partners


Advertisement